ERNA vs INTC · P/E 0.0, rev $582.0K vs rev $52.85B
Eterna Therapeutics Inc (ERNA) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. INTC currently screens at market cap $498.43B.
Not investment advice. Open the ERNA and INTC stock pages for the full models.
Not investment advice.